Rsv vaccine, pref a-pref b, recombinant Alternatives Compared
| Rsv vaccine, pref a-pref b, recombinant | Ribavirin | Synagis (palivizumab) |
|
|---|
| Rsv vaccine, pref a-pref b, recombinant | Ribavirin | Synagis (palivizumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for RSV Vaccination and Immunization, RSV. Rsv vaccine, pref a-pref b, recombinant may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hepatitis C, RSV. Ribavirin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for RSV Vaccination and Immunization, RSV. Synagis may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
| More about Rsv vaccine, pref a-pref b, recombinant | More about Ribavirin | More about Synagis (palivizumab) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Ribavirin has an average rating of 4.8 out of 10 from a total of 10 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 50% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Rsv vaccine, pref a-pref b, recombinant side effects |
View all Ribavirin side effects |
View all Synagis side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Ribavirin prices |
View all Synagis prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Abrysvo | Rebetol, RibaTab, Virazole |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
N/A |
960 hours |
432 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 304 drugs are known to interact with Rsv vaccine, pref a-pref b, recombinant:
|
A total of 18 drugs are known to interact with Ribavirin:
|
A total of 4 drugs are known to interact with Synagis:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
June 03, 1998 |
June 19, 1998 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.